Factors Associated with Adverse Reactions to BNT162b2 COVID-19 Vaccine in a Cohort of 3969 Hospital Workers

被引:8
作者
Rivera-Izquierdo, Mario [1 ,2 ,3 ]
Soler-Iborte, Eva [1 ]
de Rojas, Javier Perez [1 ]
Pegalajar-Garcia, Maria Dolores [4 ]
Gil-Villalba, Ana [4 ]
Ruiz-Villaverde, Ricardo [3 ,4 ]
Valero-Ubierna, Maria del Carmen [1 ]
机构
[1] Hosp Univ San Cecilio, Serv Prevent Med & Publ Hlth, Granada 18016, Spain
[2] Hosp Univ San Cecilio, Dept Prevent Med & Publ Hlth, Granada 18016, Spain
[3] Inst Biosanitario Granada ibs GRANADA, Granada 18012, Spain
[4] Hosp Univ San Cecilio, Serv Dermatol, Granada 18016, Spain
关键词
vaccination; COVID-19; adverse events; reactions; symptoms; healthcare; professionals; Comirnaty; Pfizer;
D O I
10.3390/vaccines10010015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Factors associated with adverse reactions to BNT162b2 COVID-19 vaccine reported by hospital workers are unclear. Our aim was to collect all reported adverse events in a cohort of hospital workers and to analyze the factors associated with their presence. We conducted an observational longitudinal study on all hospital workers of our center who received COVID-19 vaccination from 27 December 2020 to 1 September 2021. Information on adverse events was reported telephonically and confirmed through clinical records. Chi-square and t tests as well as multivariate logistic regression models were used. Cluster analysis was designed to explore associations between reactions. A total of 3969 hospital workers were included in the sample. Of the total sample, 182 workers (4.6%) reported adverse events. The most frequent symptoms were general malaise (n = 95), fever (n = 92), arthromyalgia (n = 80), and headache (n = 47). The factors associated with adverse events in adjusted analyses were an antecedent of COVID-19 infection (OR = 2.09, 95% CI: 1.47-2.98), female sex (OR = 1.51, 95% CI: 1.03-2.20), and professional category (OR for physicians = 0.41, 95% CI: 0.21-0.80). We report a low frequency of adverse events in hospital workers after COVID-19 vaccination and no severe reaction. Men and physicians underreported their symptoms. These data should guide future strategies for recording adverse events and future research on COVID-19 vaccination safety.
引用
收藏
页数:10
相关论文
共 13 条
[1]  
Coggins SA, 2022, OPEN FORUM INFECT DI, V9, DOI [10.1101/2021.06.25.21259544, 10.1093/ofid/ofab575]
[2]   COVID-19 vaccines: where we stand and challenges ahead [J].
Forni, Guido ;
Mantovani, Alberto .
CELL DEATH AND DIFFERENTIATION, 2021, 28 (02) :626-639
[3]  
Hajiabdolbaghi Mahboube, 2010, Acta Med Iran, V48, P95
[4]   Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age [J].
Hurley, Donald ;
Griffin, Carl ;
Young, Mariano, Jr. ;
Scott, Daniel A. ;
Pride, Michael W. ;
Scully, Ingrid L. ;
Ginis, John ;
Severs, Joseph ;
Jansen, Kathrin U. ;
Gruber, William C. ;
Watson, Wendy .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) :E1489-E1497
[5]   COVID-19 vaccines: breaking record times to first-in-human trials [J].
Kim, Young Chan ;
Dema, Barbara ;
Reyes-Sandoval, Arturo .
NPJ VACCINES, 2020, 5 (01)
[6]   COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines [J].
Meo, S. A. ;
Bukhari, I. A. ;
Akram, J. ;
Meo, A. S. ;
Klonoff, D. C. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (03) :1663-1669
[7]   Neutralizing Anti-SARS-CoV-2 Antibody Titer and Reported Adverse Effects, in a Sample of Italian Nursing Home Personnel after Two Doses of the BNT162b2 Vaccine Administered Four Weeks Apart [J].
Modenese, Alberto ;
Paduano, Stefania ;
Bargellini, Annalisa ;
Bellucci, Rossana ;
Marchetti, Simona ;
Bruno, Fulvio ;
Grazioli, Pietro ;
Vivoli, Roberto ;
Gobba, Fabriziomaria .
VACCINES, 2021, 9 (06)
[8]   Causal relationship between immunological responses and adverse reactions following vaccination [J].
Nakayama, Tetsuo .
VACCINE, 2019, 37 (02) :366-371
[9]   Adverse Effects on Work and Daily Life Interference among Healthcare Workers after the First and Second ChAdOx1 and BNT162b2 COVID-19 Vaccine Doses [J].
Park, Chulyong ;
Sakong, Joon ;
Jo, Seongmin ;
Kim, Minkeun ;
Baek, Kiook .
VACCINES, 2021, 9 (08)
[10]   Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine [J].
Polack, Fernando P. ;
Thomas, Stephen J. ;
Kitchin, Nicholas ;
Absalon, Judith ;
Gurtman, Alejandra ;
Lockhart, Stephen ;
Perez, John L. ;
Perez Marc, Gonzalo ;
Moreira, Edson D. ;
Zerbini, Cristiano ;
Bailey, Ruth ;
Swanson, Kena A. ;
Roychoudhury, Satrajit ;
Koury, Kenneth ;
Li, Ping ;
Kalina, Warren V. ;
Cooper, David ;
Frenck, Robert W., Jr. ;
Hammitt, Laura L. ;
Tureci, Ozlem ;
Nell, Haylene ;
Schaefer, Axel ;
Unal, Serhat ;
Tresnan, Dina B. ;
Mather, Susan ;
Dormitzer, Philip R. ;
Sahin, Ugur ;
Jansen, Kathrin U. ;
Gruber, William C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (27) :2603-2615